SuperSeed Accelerator Logo

Access investors, insights and customers at SuperSaaS, the one-day accelerator for pre-seed & seed-stage B2B AI/SaaS teams.

Access investors, insights and customers at SuperSaaS, the one-day accelerator for pre-seed & seed-stage B2B AI/SaaS teams.

SuperSaaS V

December 9, 2024

Goodwin Procter London

Sancroft, 10-15 Newgate St

London EC1A 7AZ

Apply Now

Meet CPOs from Global 2000 companies

Meet leading early stage investors

Learn to build, sell and raise

Founders – want to meet c-suite executives of over 30 global enterprises, and get the inside track on building product, GTM strategy and product-market fit?

Learn from investors, C-suite buyers and exited entrepreneurs sharing frameworks and learnings from decades of building, buying and selling. By invite only and limited to 30 startups.

Meet investors

Meet leading early-stage VC investors on the day:

Access to Customers and Partners

Meet global corporates and unlock partnerships and potential customer relationships. We work with global companies in finance, FMCG, automotive, aerospace, pharma and much more. SuperSaaS is an opportunity to meet firms like:

Meet Past Cohorts

Dreamers, thinkers, doers. SuperSaaS attendees have what it takes to go from inspirational vision to razor-sharp execution.

Verisian

New medical drugs are introduced to cure diseases in order to improve (and in many cases save) lives. The faster we can (safely) get the right drugs to market, the faster we can help patients in need. But the process to get new drugs to market is complicated, and not only for medical reasons. The statistical and data processing work required to get a phase three clinical trial ready for FDA approval can add 6 months to the project timeline. Enter Verisian. Between them, co-founders Tomas Sabat and Henning Kuich have a wealth of experience in data structures and medical data analysis. With their new company they helping the pharmaceutical industry benefit from next-generation data science, so those delays can be compressed and new drugs can get faster to patients.

Popp

Surgeon-turned-tech executive Sam Dhesi found himself in the heat of the action when was asked to rapidly scale the UK government’s Emerging Tech capability during the pandemic. Sam knew how important it was to get each hire right, but also saw how laborious it was to go through thousands of applicants to find those who perfectly fit the bill. With Popp, Sam and his cofounders Ilyes Benmansour and James Cochrane-Dyet are leveraging AI to transform how hiring is done, helping large organisations everywhere find top talent at scale.

Access to Investors

A fast track to the ideal seed round

Learn the craft of how to nail the best pitch

Meet the most relevant investors on the day

Match-making with additional investors after the event

Access to Insights

Building a successful B2B SaaS company is hard. Meet successful SaaS founders who've built and exited multiple companies, and get their insights on how to create a winning business.

Feel the love

Questions?

If you have any further questions, please feel free to reach out.

No, the whole day is on us.

Must be Pre-Series A. Pre-revenue and MVP is welcome – this is an opportunity to refine your concept.

Any startup from across Europe, Israel, Turkey, UK.

Win with us

Meet CPOs from Global 2000 companies
Meet leading early stage investors
Learn to build, sell and raise

Apply Now

SuperSaaS V

December 9, 2024


Goodwin Procter London

Sancroft, 10-15 Newgate St

London EC1A 7AZ